Skip to content
★ Sign in to follow
ML

Mark L. Portnoy

Co-Président
Cryo Cell International Inc
Total declarations
55
Company
1
▲ Purchases (37 ops.)
€434k
▼ Sales (8 ops.)
€744k

Latest filing published 29 Aug 2022 for Cryo Cell International INC, €187k.

Filing timeline

BuySale
Mark L. Portnoy

Insider track record

Disclosed buys
37
Disclosed sells
8
Signal history

Closed purchases

Market purchases
37
Positive at T+90
15%
Median T+90
-0.7%

Based on 34 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Mark L. Portnoy: trading record in brief

This profile gathers the share dealings of Mark L. Portnoy in Cryo Cell International Inc, where the filings describe the role as chief executive. We count 55 filings; the first trade dates from 19 October 2012 and the latest from 25 August 2022.

Both buying and selling appear: 37 purchases worth €434k, against 8 sales worth €744k. Taken together, the sales exceed the purchases by €309k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 6 share grants and 4 option exercises.

In size, the median ticket on the buying side is €4,380. Of 21 purchases, 20 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 34 purchases old enough to measure, the stock rose over the following 90 days in 15% of cases; the median change was -0.7%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 29 August 2022 with an option exercise (€187k) in Cryo Cell International Inc. The last insider purchase was made public on 28 July 2020, 2,294 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Mark L. Portnoy

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations53 total
  • ◇
    Co-CEOExecutivesCryo Cell International Inc
    186,701 USD25SEC
    59,459 shares@ US$3.1429.4% of flowCommon StockSEC:0001209191-22-047881:0
  • ◆
    Co-CEOExecutivesCryo Cell International Inc
    267,750 USD23SEC
    25,500 shares@ US$10.5012.1% of flowCommon StockSEC:0001209191-21-053499:1
  • ◇
    Co-CEOExecutivesCryo Cell International Inc
    196,666 USD25SEC
    67,816 shares@ US$2.9026.3% of flowCommon StockSEC:0001209191-21-053499:0
  • ◇
    Co-CEOExecutivesCryo Cell International Inc
    93,334 USD28SEC
    32,184 shares@ US$2.904.1% of flowCommon StockSEC:0001209191-21-035965:1
  • ◇
    Co-CEOExecutivesCryo Cell International Inc
    344,000 USD26SEC
    200,000 shares@ US$1.7244.3% of flowCommon StockSEC:0001209191-21-035965:0
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    33,000 USD43SEC
    4,000 shares@ US$8.253.4% of flowCommon stockSEC:0000899243-20-020559:0
    Canonical exit: 22 Oct 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    41,250 USD43SEC
    5,000 shares@ US$8.254.2% of flowCommon stockSEC:0000899243-20-020559:1
    Canonical exit: 22 Oct 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    10,000 USD40SEC
    1,250 shares@ US$8.001.0% of flowCommon stockSEC:0000899243-20-019697:0
    Canonical exit: 14 Oct 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    996 USD40SEC
    131 shares@ US$7.600.1% of flowCommon stockSEC:0000899243-20-019697:1
    Canonical exit: 14 Oct 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    4,000 USD40SEC
    500 shares@ US$8.000.4% of flowCommon stockSEC:0000899243-20-019697:2
    Canonical exit: 18 Oct 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    1,502 USD43SEC
    200 shares@ US$7.510.2% of flowCommon stockSEC:0000899243-20-019195:0
    Canonical exit: 11 Oct 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    3,490 USD37SEC
    500 shares@ US$6.980.2% of flowCommon stockSEC:0000899243-20-016673:0
    Canonical exit: 10 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    11,900 USD37SEC
    1,700 shares@ US$7.000.8% of flowCommon stockSEC:0000899243-20-016673:1
    Canonical exit: 10 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    9,154 USD37SEC
    1,237 shares@ US$7.400.6% of flowCommon stockSEC:0000899243-20-016673:2
    Canonical exit: 10 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    5,723 USD37SEC
    763 shares@ US$7.500.4% of flowCommon stockSEC:0000899243-20-016673:3
    Canonical exit: 10 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    710 USD37SEC
    100 shares@ US$7.100.1% of flowCommon stockSEC:0000899243-20-016673:4
    Canonical exit: 10 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    631 USD37SEC
    100 shares@ US$6.310.0% of flowCommon stockSEC:0000899243-20-016673:5
    Canonical exit: 10 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    650 USD37SEC
    100 shares@ US$6.500.0% of flowCommon stockSEC:0000899243-20-016673:6
    Canonical exit: 10 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    10,220 USD37SEC
    1,400 shares@ US$7.300.7% of flowCommon stockSEC:0000899243-20-016673:7
    Canonical exit: 10 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    1,871 USD37SEC
    268 shares@ US$6.980.1% of flowCommon stockSEC:0000899243-20-016673:9
    Canonical exit: 10 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    5,117 USD37SEC
    732 shares@ US$6.990.4% of flowCommon stockSEC:0000899243-20-016673:10
    Canonical exit: 10 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    27,473 USD43SEC
    3,330 shares@ US$8.251.9% of flowCommon stockSEC:0000899243-20-016673:11
    Canonical exit: 13 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    10,500 USD43SEC
    1,400 shares@ US$7.500.7% of flowCommon stockSEC:0000899243-20-016673:12
    Canonical exit: 13 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc
    41,500 USD43SEC
    5,000 shares@ US$8.302.9% of flowCommon stockSEC:0000899243-20-016673:13
    Canonical exit: 13 Sept 2020 (T+90)
  • ▲
    Co-Chief Executive OfficerExecutivesCryo Cell International Inc

    Same trade as the filing by David Portnoy, counted once

    11,985 USD37SEC
    1,500 shares@ US$7.990.8% of flowCommon stockSEC:0000899243-20-016673:8
    Canonical exit: 10 Sept 2020 (T+90)

25 of 53 declarations